Curriculum vitae

PERSONAL INFORMATION Concepcion Prieto Yerro

WORK EXPERIENCE

2005–Present Technical adviser for the Department of Drugs for Human UseSpanish Agency for Drugs and Medical Devices (Spain)

Head of the Centralised Procedure Unit (coordinating all activities related to the centralised procedure applications)

CHMP member from Spain

2001–2005 Head of Service of Clinical Assessment and PharmacologySpanish Agency for Drugs and Medical Devices (Spain)

Clinical assessor (Cardiovascular, SNC, ophtalmology, lung diseases, urology)

1994–1996 Coordinator of the Program of Rational of Drugs in Primary CareNational Health Service - Primary Care - Sector 4 Madrid (Spain)

Drug information activities

1992–1994 Assessor of the Department of Health PromotionNational School of Health (Spain)

Health education, health promotion, use of drugs

1990–1992 Assessor of the Division of Pharmaceutical ProvisionMinistry of Health - Madrid (Spain)

Development and implementation of the Program of Rational Use of Drugs in Primary Care

1985–1990 General practitioner - Primary careNational Health Service (Spain)

Clinical practice in primary care

EDUCATION AND TRAINING

1977–1984 Degree in Medicine and Surgery (MD), 1984School of Medicine. Universidad Complutense de Madrid (Spain)

Medicine and Surgery

1994– PhD (Doctorate), 1994Universidad Autónoma de Madrid - Spain (Spain)

Rational Use of Drugs in Primary Care

1996–2000 Specialist in Clinical PharmacologyHospital Universitario Clínico de San Carlos- Madrid (Spain)

Two years of rotations in internal medicine, haematology, nephrology and neurology units. Four years as duty doctor in emergency department. Four-year training in matters related to clinical pharmacology issues (drug utilisation studies, drug monitoring...)

3/11/17 © European Union, 2002-2017 | http://europass.cedefop.europa.eu Page 1 / 3

Curriculum vitae Concepcion Prieto Yerro

ADDITIONAL INFORMATION

Expertise Cardiovascular

Ophtalmology

Urology

Radiopharmaceutical products

Clinical Pharmacology

Respiratory

Publications 1.- Prieto Yerro C, López Corbalán JC. Utilización de antihipertensivos en Baleares y su análisis comparativo en el periodo 1981-86. Inf Ter Segur Soc 1988; 12:97-9

2.- Garcia Iñesta A, Prieto Yerro C. Utilización de antiinfecciosos en España en el periodo 1981-1987. Inf Ter Segur Soc 1988;12:181-92

3.- Iñesta A, Prieto Yerro C. Utilización de cloranfenicol en el periodo 1982-1987. Inf Ter Segur Soc 1989;13:148-59

4.- Prieto I, Prieto C, Sacristán A. Utilización de analgésicos narcóticos en el tratamiento del dolor. Inf Ter Sist Nac Salud 1991;15:180-6

5.- Cortés E, Cuesta T, Ferré P, Rodriguez A, Prieto C. Nuevos pricipios activos comercializados en España en 1991. Inf Ter Sist Nac Salud 1992;16(4):79-95

6.- Sacristán Rodea A, Terol García E, Prieto Yerro C. Estudio de un programa de cuidados paliativos a domicilio. Atención Primaria. Area 4 del INSALUD. Madrid. 1996

7.- Palanca Sánchez I, Prieto Yerro C, Sacristán Rodea A. Prestación y políticas farmacéuticas. La salud y los servicios sanitarios en la Comunidad de Madrid. AMA 1996:327-333

8.- García Arenillas M, Prieto Yerro C, Portolés Pérez A. Utilización de medicamentos en el embarazo, lactancia, niños y ancianos. Medicine 1999;130:6158-66

9.- Moreno González A, Vargas Castrillón E, Gassent Balaguer C, Laredo Velasco L, Prieto Yerro C. Guía farmacológica en podología. Federación Española de Podólogos. Madrid, 1999

10.- Prieto Yerro C, Vargas Castrillón E. Uso de AINE en pacientes con patología crónica asociada. Inf Ter Sist Nac Salud 2000;24(4):85-91

11.- Prieto Yerro C, Pérez López C, Rodriguez Bernardino A, Martinez Martinez R, del Potro Gómez E, Alvarez Carmona A. Relapsing pancytopenia following exposure and re-exposure to cyanamide. Eur J Haematology 2000;65:1-2

12.- Prieto Yerro C, Vargas Castrillón E, Laredo Velasco L, Pérez-Cecilia E, Ambit Avila I, Picazo de laGarza JJ. Utilización de Anfotericina B no convencional en el hospital Clínico de San Carlos. Rev Esp Salud Pública 2000;74:345-53

13.- Prieto Yerro C, Rodriguez Bernardino A, Vargas Castrillón E. Utilización de propacetamol en el Hospital Clínico de San Carlos. Atención Farmacéutica 2000; 2(6): 534-8

14.- Prieto Yerro C, Vargas Castrillón E, Laredo Velasco L, Pérez-Cecilia E, Ambit Avila I, Picazo de laGarza JJ. Modificación en el patrón de uso de anfotericina B no convencional tras una intervención formativa en el hospital Clínico de San Carlos. Rev Esp Salud Pública 2001;75(2):353-60

15.- Moreno González, A; Prieto Yerro, C; Vargas Castrillón, E, Laredo Velasco, L, Asenjo Correa, S. Profilaxis del tromboembolismo venoso en paciente no quirúrgicos. Medifam 2002; 12 (6): 369-378

16.- M Berntgen, H. Enzmann; E. Schabel, C. Prieto Yerro, A. Gómez-Outes, T. Samonson, J. Musaus. Linaclotide for treatment of irritable bowel syndrome-The view of the European regulators. Dig Liver Dis. 2013 Sep;45(9):724-6.

17.- Cortes-Blanco A, Prieto Yerro C, et al. Florbetapir (18F) for brain amyloid positron emission tomography: Highlights on the European marketing approval. Alzheimer's and Dementia 2014;10 (5): S395–S399.

18.- Haas M, Prieto Yerro C et al. European Medicines Agency review of ataluren for the treatment of ambulant patients aged 5 years and older with Duchene muscular dystrophy resulting from a nonsense mutation in the dystrophin gene. Neuromuscular disorder 2015; 25 (1): 5–13

Projects

3/11/17 © European Union, 2002-2017 | http://europass.cedefop.europa.eu Page 2 / 3

Curriculum vitae Concepcion Prieto Yerro

Memberships From 2005-2010 alternate at the CHMP from Spain.

From 2003-2006 member of the Ethics Committee of Universitary Hospital of Mostoles (Madrid, Spain).

From 2013 member of the Patients' and Consumers' Working Party.

From 2016 member of the Respiratory Drafting Group.

Member of the Spanish National Board on Human Medicines.

Peer Reviewer for the “Revista Española de Salud Pública".

Other Relevant Information Master's degree in Methodology of the Investigation (400 h)

3/11/17 © European Union, 2002-2017 | http://europass.cedefop.europa.eu Page 3 / 3